Raju Kucherlapati Insider Profile

4 Followers
Raju Kucherlapati, Director at AVEO Pharma, holds 190.26K shares in Gelesis Holdings (Ticker: GLSHQ), holds 195.41K shares in AVEO Pharma (Ticker: AVEO). Most recently, Raju Kucherlapati Bought ― shares of Gelesis Holdings on Nov 22, 2022 for an estimated value of 44.52K.
tipranks
Raju Kucherlapati

Raju Kucherlapati
AVEO Pharma (AVEO)
Director

Ranked #92,030 out of 99,335 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-95.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4K
100.00%
A breakdown of Raju Kucherlapati's holdings

Insider Roles

Gelesis Holdings
(GLSHQ)
Director
Roles that Raju Kucherlapati holds in companies

Most Profitable Insider Trade

Stock:
Gelesis Holdings
(GLSHQ)
Rating:Informative Buy
Date:Jan 19, 2022 - Jan 19, 2023
Return:-94.30%
The most profitable trade made by Raju Kucherlapati

Raju Kucherlapati's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AVEO
AVEO Pharma
May 30, 2013
Uninformative Buy
$2.93M
Gelesis Holdings
Nov 22, 2022
Director
Informative Buy
44.52K
$3.62K
List of latest transactions for each holding click on a transaction to see Raju Kucherlapati's performance on stock

Raju Kucherlapati insider profile FAQ

What is the percentage of profitable transactions made by Raju Kucherlapati?
The percentage of profitable transactions made by Raju Kucherlapati is 0%.
    What is the average return per transaction made by Raju Kucherlapati?
    The average return per transaction made by Raju Kucherlapati is -95.90%.
      What stocks does Raju Kucherlapati hold?
      Raju Kucherlapati holds: AVEO, GLSHQ stocks.
        What was Raju Kucherlapati’s latest transaction?
        Raju Kucherlapati latest transaction was an Informative Buy of $44.52K.
          What was Raju Kucherlapati's most profitable transaction?
          Raju Kucherlapati’s most profitable transaction was an Informative Buy of GLSHQ stock on January 19, 2022. The return on the trade was -94.30%.
            What is Raju Kucherlapati's role in AVEO Pharma?
            Raju Kucherlapati's role in AVEO Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.